Paradoxical inflammation revisited: muraglitazar and cardiovascular risk.
Yun
Anthony J
AJ
Lee
Patrick Y
PY
Doux
John D
JD
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D005998:Glycine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D010080:Oxazoles / Q000009:adverse effects*; D012306:Risk
D007004:Hypoglycemic Agents; D010080:Oxazoles; D005998:Glycine; C500085:muraglitazar